Select Investments

atai Life Sciences AG is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders.
Beta Bionics® is a clinical stage medical technology company focused on the design, development, and commercialization of its iLet® Bionic Pancreas, currently an investigational device intended to achieve near-normal glycemia and lift the cognitive daily burden of diabetes management.
Caris Life Sciences helps patients, clinicians, researchers, and payors navigate, advance and reinvent cancer care, using expertise, proprietary technologies, clinical testing capabilities, and extensive library of clinical data to advance precision medicine.
Cathworks Ltd. is dedicated to improving the care of patients suffering from coronary artery disease by using advanced computational science and artificial intelligence to optimize treatment decisions.
Claret Medical Inc. developed and commercialized the Sentinel® Cerebral Embolic Protection System, used to protect the brain during certain interventional procedures, predominately in TAVR patients.
Cleerly is creating a new standard of heart care. Through its FDA-cleared diagnostic tools driven by machine intelligence, Cleerly’s analysis of non-invasive CCTA enables comprehensive phenotyping of coronary artery disease.
Establishment Labs Holdings Inc. (NASDAQ:ESTA) designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants.
Exo is pioneering a high-performance handheld ultrasound platform and AI for imaging and therapeutic applications. By delivering easy-to-use, high quality medical imaging, Exo empowers healthcare professionals to make real-time decisions to improve patient outcomes.
Freenome is developing a comprehensive multiomics platform for early cancer detection using a routine blood draw.
Genalyte Inc. is a diagnostics and analytics company that improves patient outcomes and lowers cost by offering real-time laboratory results, delivering rapid, actionable results to doctors through decentralized laboratory testing.
Imperative Care develops leading-edge tools and technology for improving clinical outcomes today, while also working to close the gaps in stroke prevention, detection, rehabilitation, and long-term recovery in the future.
LUMICKS is the leading supplier of Dynamic Single-Molecule and Cell Avidity analysis instruments which enable the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells.
Metagenomi is a gene editing company committed to developing potentially curative therapeutics by leveraging a proprietary toolbox of next-generation gene editing systems to accurately edit DNA where current technologies cannot.
Monogram Health is a leading value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease.
Nalu is a medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic neuropathic pain, and providing a differentiated value proposition for patients and physicians.
NanoMosaic is the only commercial entity to leverage the power of nanoneedles, MosaicNeedles™, for protein detection and quantification to develop best-in-class assays for biomarker discovery and validation.
Quanta creates beautifully engineered devices and services that improve dialysis experiences and everyday living, with the purpose of empowering better experiences and enabling access to the highest-quality shared and self-care therapies.
Ultivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology to strengthen and accelerate biomarker discovery and drug development programs.
Vizgen Corp. is developing the next generation of spatially resolved transcriptomic profiling tools to provide new insight into the biological systems that underlie human health and disease.
V-Wave Ltd. is focused on developing percutaneous implantable devices for treating patients with chronic Heart Failure (HF).
Willow Innovations, Inc. is the creator of the Willow Wearable Breast Pump. With no cords, wires, or dangling bottles, plus an app that keeps track of pumping habits, women can breastfeed without giving up their freedom, their dignity, or themselves.
This data is for informational purposes only and is not intended as an offer or solicitation with respect to the purchase or sale of any security or of any fund Pura Vida Investments LLC or its affiliates (collectively, “Pura Vida”) manages or offers. The specific securities identified on this page do not represent all of the securities purchased, sold or recommended by Pura Vida and you should not assume that investments in the securities identified will ultimately be profitable. Pura Vida may increase or decrease its position in any of the securities identified, and may invest in additional private companies. This information is subject to change without notice.
Scroll to Top